DigestiveICD-10: K63.89Estimated to affect up to 15-20% of the general population, higher among IBS patients

Small Intestinal Bacterial Overgrowth (SIBO)

Small intestinal bacterial overgrowth (SIBO) is a condition in which excessive amounts of bacteria colonize the small intestine, leading to digestive symptoms and malabsorption of nutrients. Normally, the small intestine has relatively few bacteria compared to the large intestine, and SIBO disrupts this balance. SIBO is increasingly recognized as an underlying cause of irritable bowel syndrome (IBS) symptoms and can result in nutritional deficiencies if left untreated.

Last updated October 31, 2026

Understanding Small Intestinal Bacterial Overgrowth (SIBO)

Small intestinal bacterial overgrowth means the small intestine, which normally carries a sparse bacterial population, has acquired colon-like numbers, conventionally more than 1,000 organisms per millilitre of fluid from the upper small bowel. Those bacteria ferment food before you can absorb it, producing hydrogen, methane or hydrogen sulfide, bloating and altered stools. SIBO is a consequence of something else going wrong rather than a disease that appears on its own, and the thing that went wrong matters more for long-term control than the antibiotic course. Its popularity as a diagnosis has outrun the science: breath tests are imperfect, overgrowth turns up in some healthy people, and the sweeping claim that most IBS is really SIBO has not survived careful study, although a meaningful minority of people with IBS-type symptoms do have it.

Three defenses normally keep the small bowel clean: stomach acid kills swallowed bacteria, the migrating motor complex sweeps the fasting gut every 90 to 120 minutes, and the ileocecal valve stops colon contents flowing backward. Anything that weakens one invites overgrowth: long-term acid suppression, diabetic or scleroderma-related nerve damage, opioids, hypothyroidism, previous abdominal surgery, adhesions, diverticula or a damaged valve. Once established, the bacteria deconjugate bile acids, so fat is poorly absorbed, and they consume vitamin B12 while producing folate, giving the odd pattern of low B12 with high folate. Methane is made not by bacteria but by archaea, chiefly Methanobrevibacter smithii, and it slows transit, which is why methane-dominant overgrowth (now called intestinal methanogen overgrowth, IMO) presents with constipation while hydrogen-dominant SIBO tends toward diarrhea.

Untreated, SIBO fluctuates with the underlying cause and can lead to weight loss, anemia and fat-soluble vitamin deficiency in severe cases, though most people have bloating rather than malnutrition. Conventional treatment is rifaximin, a gut-restricted antibiotic, usually 550 mg three times daily for 14 days; pooled data from 32 studies give an eradication rate of about 71%, higher at larger doses. Methane overgrowth responds better to rifaximin combined with neomycin or metronidazole. Symptoms improve in most people who clear the overgrowth, but recurrence is the central problem: in one series, 44% had relapsed by nine months, with older age, prior appendectomy and PPI use predicting it. Nighttime prokinetics (low-dose erythromycin, prucalopride) extend remission, and stopping unnecessary PPIs, treating diabetes or thyroid disease, and tackling motility are what keep it away. An elemental diet for two to three weeks is an alternative to antibiotics, normalizing breath tests in about 80%, but is hard to tolerate.

No natural approach has strong evidence, so this section ranks moderate and preliminary options honestly. The best-known data are a 2014 Johns Hopkins study of 104 patients in which a four-week course of commercial herbal antimicrobial blends (containing oregano, thyme, berberine-rich herbs, wormwood and others) normalized breath tests in 46% versus 34% on rifaximin, a difference that was not statistically significant, and worked in 57% of rifaximin failures. It was not randomized and used combinations, so the credit cannot be assigned to one herb; our entries for oregano oil, berberine and wormwood reflect that. Partially hydrolyzed guar gum has a randomized trial showing it raises rifaximin eradication from 62% to 87%. Peppermint oil and ginger address symptoms and motility rather than the overgrowth. Probiotics are contested: pooled studies suggest they help clear overgrowth, but some people with SIBO report worse bloating and brain fog on them. The low-FODMAP diet reduces symptoms by starving the fermenters but eradicates nothing and is not a long-term solution.

The mistake people make most is chasing a breath test number through repeated antibiotic or herbal rounds while never asking why the bacteria keep coming back. Lactulose breath tests give a positive result in up to a fifth of healthy volunteers, mostly because of fast transit to the colon, and a normal test does not exclude overgrowth, so the result has to be read alongside symptoms and risk factors. The second mistake is permanent food restriction: shrinking the diet to a handful of foods lowers symptoms for a while, reduces microbial diversity, and often adds a second problem, disordered eating, to the first.

At a Glance

Common symptoms
Abdominal bloating and distension, especially after meals, Excess gas and flatulence, Abdominal pain and cramping
Main treatments
Antibiotic therapy (rifaximin) targeted at gut bacteria, Elemental diet as an alternative to antibiotics for 2-3 weeks, Prokinetic medications to improve small intestine motility
Category
Digestive · Estimated to affect up to 15-20% of the general population, higher among IBS patients
See a doctor if
Chronic bloating, gas, and abdominal discomfort persist despite dietary changes

Symptoms

Abdominal bloating and distension, especially after meals
Excess gas and flatulence
Abdominal pain and cramping
Diarrhea, constipation, or alternating between both
Nausea and feeling of fullness
Unintended weight loss
Fatigue and brain fog from nutrient malabsorption
Fatty stools (steatorrhea)

Causes

  • Impaired small intestine motility due to conditions like diabetes, scleroderma, or hypothyroidism
  • Structural abnormalities such as intestinal strictures, adhesions, or surgical blind loops
  • Reduced stomach acid production from proton pump inhibitor use or atrophic gastritis
  • Immune deficiency or dysfunction affecting gut defense mechanisms
  • Ileocecal valve dysfunction allowing backflow from the colon

Risk Factors

  • Use of proton pump inhibitors or other acid-suppressing medications
  • History of abdominal surgery
  • Diabetes mellitus with associated gastroparesis
  • Irritable bowel syndrome (IBS)
  • Chronic pancreatitis or liver cirrhosis
  • Advanced age
  • Hypothyroidism

Diagnosis

  • Lactulose or glucose hydrogen/methane breath test
  • Small bowel aspirate and culture (gold standard but invasive)
  • Blood tests to evaluate vitamin B12, iron, and folate levels
  • Comprehensive metabolic panel to assess nutritional status

Treatment

  • Antibiotic therapy (rifaximin) targeted at gut bacteria
  • Elemental diet as an alternative to antibiotics for 2-3 weeks
  • Prokinetic medications to improve small intestine motility
  • Dietary modifications such as the low-FODMAP diet to reduce symptoms
  • Correction of nutritional deficiencies (B12, iron, fat-soluble vitamins)
  • Treatment of underlying conditions contributing to SIBO

Natural remedies for small intestinal bacterial overgrowth (sibo): what the evidence says

Ranked by the strength of human evidence for small intestinal bacterial overgrowth (sibo) specifically. These sit alongside medical care, not in place of it.

  1. Oregano oil

    Moderate evidence

    Oregano oil was a core ingredient in both herbal blends tested in the 2014 study of 104 SIBO patients, where four weeks of herbal therapy normalized lactulose breath tests in 46% versus 34% for rifaximin 1,200 mg daily, with no significant difference and a 57% response among rifaximin failures. Its carvacrol and thymol are broad-spectrum antimicrobials in the laboratory. No trial has tested oregano oil alone in SIBO.

    Studied dose
    Emulsified or enteric-coated oregano oil standardized to carvacrol, 200 mg two to three times daily with food for 4 weeks, within a combination protocol.
    Cautions
    Avoid in pregnancy and breastfeeding. Can irritate the stomach and reduce iron absorption; take iron separately. May add to the effect of blood thinners and glucose-lowering drugs. Limit courses to 4 to 6 weeks to spare beneficial bacteria.
  2. Berberine

    Moderate evidence

    Berberine-containing herbs (coptis, barberry, goldenseal) were in the 2014 herbal blends that matched rifaximin for breath-test normalization. Separately, in a 132-patient placebo-controlled trial in IBS-D, berberine 200 mg twice daily for eight weeks reduced diarrhea frequency, urgency and abdominal pain, and it is antimicrobial and anti-secretory against gut bacteria in laboratory studies. Trials of berberine alone in SIBO are lacking.

    Studied dose
    400 to 500 mg two to three times daily with meals for 4 to 8 weeks.
    Cautions
    Inhibits CYP3A4 and CYP2D6, raising levels of cyclosporine, tacrolimus, some statins and many other drugs; adds to the glucose-lowering effect of metformin and insulin. Avoid in pregnancy, breastfeeding and newborns. Can constipate, so use cautiously in methane-type overgrowth.
  3. In a randomized trial of 77 SIBO patients, adding PHGG 5 g daily to a 10-day course of rifaximin 1,200 mg raised breath-test eradication from 62% to 87% and improved symptoms more than rifaximin alone. The soluble fiber is thought to push bacteria into an active, antibiotic-susceptible state and support normal motility. It is one of the few single-ingredient interventions in SIBO with a controlled trial.

    Studied dose
    5 g once daily in water or food, started with the antibiotic or herbal course and continued for 4 to 12 weeks.
    Cautions
    Mild gas in the first week; may transiently increase bloating in hydrogen-dominant overgrowth. Separate from medicines by 2 hours. Safe in pregnancy at food doses.
  4. Wormwood was a component of one of the herbal blends in the 2014 SIBO comparison and is antimicrobial and antiparasitic in laboratory studies. The only stand-alone human trials are in Crohn's disease, where 750 mg daily for 10 weeks allowed steroid tapering in 65% of patients versus none on placebo. There is no trial of wormwood alone in SIBO, so its role is as a short-course ingredient in combinations.

    Studied dose
    250 to 500 mg standardized, thujone-reduced extract two or three times daily for no more than 4 weeks, within a combination protocol.
    Cautions
    Contains thujone, which is neurotoxic at high or prolonged doses; never use the essential oil internally. Avoid in pregnancy, breastfeeding, epilepsy and kidney disease. May interact with anticonvulsants and warfarin. Allergy cross-reacts with ragweed.
  5. Peppermint oil does not clear overgrowth, but it treats the bloating, cramping and pain that drive people to seek a SIBO diagnosis. In IBS, which overlaps heavily with SIBO, pooled data from 12 trials give a number needed to treat of about 3 for global symptoms, and menthol has antimicrobial activity in the laboratory. It is a reasonable symptom bridge during and after antimicrobial treatment.

    Studied dose
    180 to 225 mg enteric-coated capsules 2 to 3 times daily before meals for 4 to 12 weeks.
    Cautions
    Worsens heartburn by relaxing the esophageal sphincter. Avoid in children under 8 and with bile duct obstruction. Can raise cyclosporine levels; antacids may dissolve the coating early. Swallow whole.
  6. Ginger (as a prokinetic)

    Preliminary evidence

    Weak motility is the commonest reason SIBO returns, and prokinetic drugs extend remission. Ginger speeds gastric emptying in controlled studies (1.2 g shortened half-emptying time from 16 to 12 minutes in functional dyspepsia) and stimulates antral contractions, which is why it appears in most herbal prokinetic formulas. No trial has tested ginger for SIBO prevention; the rationale is mechanistic.

    Studied dose
    1 g dried ginger or standardized extract at bedtime, often combined with artichoke extract, continued for 3 months after treatment.
    Cautions
    Antiplatelet effect; caution with warfarin and other blood thinners and stop before surgery. Safe up to 1 g daily in pregnancy. High doses cause heartburn.
  7. Saccharomyces boulardii

    Preliminary evidence

    A probiotic yeast rather than a bacterium, so it does not add to bacterial load. In a 40-patient trial in people with systemic sclerosis and SIBO, two months of S. boulardii cleared overgrowth in a third of patients and, combined with metronidazole, in 55%, with better symptom improvement than the antibiotic alone. A 2017 meta-analysis of 18 probiotic studies found a 53% decontamination rate overall, but no prevention of SIBO, and a small series linked bacterial probiotics to brain fog in some patients.

    Studied dose
    250 to 500 mg (5 to 10 billion CFU) twice daily for 4 to 8 weeks, alongside or after antimicrobial treatment.
    Cautions
    Avoid in severe immunosuppression, critical illness or with a central venous catheter, where fungal bloodstream infections have occurred. Antifungal drugs inactivate it. Rare constipation or thirst.

What matters day to day

  • Space meals 4 to 5 hours apart and avoid grazing: the migrating motor complex that sweeps the small bowel only runs in the fasting state, roughly every 90 to 120 minutes, and constant snacking switches it off.
  • Fix the root cause, because recurrence is 44% within nine months otherwise: review whether a PPI is still needed, tighten diabetes and thyroid control, and ask about a nighttime prokinetic if your motility is slow.
  • Use the low-FODMAP diet as a short-term symptom tool, not a treatment; it lowers gas production within days but does not clear overgrowth, and staying on it for months reduces beneficial bacteria.
  • Limit alcohol: in a Mayo Clinic series, moderate drinkers were markedly more likely to have a positive breath test (58% versus 38%), and alcohol impairs small-bowel motility and the gut barrier.
  • Ask about nutritional checks (B12, iron, vitamin D, folate) if symptoms have lasted months; low B12 with high folate is a classic signature of overgrowth.

Prevention

  • Avoid unnecessary long-term use of proton pump inhibitors
  • Manage underlying conditions such as diabetes and hypothyroidism
  • Eat at regular intervals and avoid frequent snacking to support the migrating motor complex
  • Stay physically active to promote healthy gut motility
  • Work with a healthcare provider to address any structural issues post-surgery

When to See a Doctor

  • Chronic bloating, gas, and abdominal discomfort persist despite dietary changes
  • You experience unexplained weight loss or signs of nutritional deficiency
  • Symptoms of IBS do not improve with standard treatment

Frequently Asked Questions

References

  1. Pimentel M, Saad RJ, Long MD, Rao SSC. ACG Clinical Guideline: Small Intestinal Bacterial Overgrowth. American Journal of Gastroenterology (2020)
  2. Quigley EMM, Murray JA, Pimentel M. AGA Clinical Practice Update on Small Intestinal Bacterial Overgrowth: Expert Review. Gastroenterology (2020)
  3. Chedid V, Dhalla S, Clarke JO, et al.. Herbal therapy is equivalent to rifaximin for the treatment of small intestinal bacterial overgrowth. Global Advances in Health and Medicine (2014)
  4. Gatta L, Scarpignato C. Systematic review with meta-analysis: rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth. Alimentary Pharmacology and Therapeutics (2017)
  5. Furnari M, Parodi A, Gemignani L, et al.. Clinical trial: the combination of rifaximin with partially hydrolysed guar gum is more effective than rifaximin alone in eradicating small intestinal bacterial overgrowth. Alimentary Pharmacology and Therapeutics (2010)
  6. Rezaie A, Buresi M, Lembo A, et al.. Hydrogen and Methane-Based Breath Testing in Gastrointestinal Disorders: The North American Consensus. American Journal of Gastroenterology (2017)
  7. Zhong C, Qu C, Wang B, Liang S, Zeng B. Probiotics for Preventing and Treating Small Intestinal Bacterial Overgrowth: A Meta-Analysis and Systematic Review of Current Evidence. Journal of Clinical Gastroenterology (2017)
  8. Rao SSC, Rehman A, Yu S, Andino NM. Brain fogginess, gas and bloating: a link between SIBO, probiotics and metabolic acidosis. Clinical and Translational Gastroenterology (2018)
  9. Lauritano EC, Gabrielli M, Scarpellini E, et al.. Small intestinal bacterial overgrowth recurrence after antibiotic therapy. American Journal of Gastroenterology (2008)
  10. Chen C, Tao C, Liu Z, et al.. A Randomized Clinical Trial of Berberine Hydrochloride in Patients with Diarrhea-Predominant Irritable Bowel Syndrome. Phytotherapy Research (2015)

Related Conditions

Related from the Supplement Library

These supplements have been studied in relation to Small Intestinal Bacterial Overgrowth (SIBO). Always consult your healthcare provider before starting any supplement, especially if you take medications.

Have questions about Small Intestinal Bacterial Overgrowth (SIBO)?

Ask Mother Nature AI for personalized, evidence-based guidance.

Medical Disclaimer: This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider.

Content reviewed against peer-reviewed medical literature and clinical guidelines. Read our editorial standards.